Markets:

Overview

News

Currencies

International

Treasuries

Enovis Corporation Common Stock (NY:ENOV)

29.60 +0.83 (+2.88%)

Official Closing Price Updated: 4:10 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enovis Corporation Common Stock

< Previous 1 2 3 4 Next >

Enovis, AMN Healthcare Services, Astrana Health, U.S. Physical Therapy, and AdaptHealth Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

November 18, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

3 Reasons to Avoid ENOV and 1 Stock to Buy Instead

November 13, 2025

Over the last six months, Enovis’s shares have sunk to $30.86, producing a disappointing 14.8% loss - a stark contrast to the S&P 500’s 16.3% gain. This might have investors contemplating their next...

Via StockStory

Topics Stocks

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

The 5 Most Interesting Analyst Questions From Enovis’s Q3 Earnings Call

November 13, 2025

Enovis’ third quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market reacted negatively to the report. Management highlighted strong organic growth across the...

Via StockStory

Topics Earnings World Trade

Q3 Earnings Outperformers: Enovis (NYSE:ENOV) And The Rest Of The Medical Devices & Supplies - Specialty Stocks

November 12, 2025

Looking back on medical devices & supplies - specialty stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers.

Via StockStory

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

3 Healthcare Stocks We Approach with Caution

November 09, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds

November 07, 2025

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the...

Via StockStory

Topics World Trade

Enovis’s (NYSE:ENOV) Q3 Sales Top Estimates

November 06, 2025

Via StockStory

Enovis Corp (NYSE:ENOV) Posts Mixed Q3 Results with EPS Beat and Revenue Miss ↗

November 06, 2025

Enovis Q3 2025: Adjusted EPS beats estimates, but revenue slightly misses. The company raises full-year profit guidance despite a large non-cash charge.

Via Chartmill

Enovis (ENOV) Q3 Earnings: What To Expect

November 04, 2025

Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

1 Russell 2000 Stock Worth Your Attention and 2 We Avoid

October 24, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

1 Unprofitable Stock to Own for Decades and 2 Facing Challenges

October 16, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Why Enovis (ENOV) Stock Is Trading Up Today

October 14, 2025

Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the afternoon session after the company announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity...

Via StockStory

Topics Artificial Intelligence Economy Government

Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Enovis (ENOV) Stock Trades Up, Here Is Why

October 08, 2025

Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 4.3% in the afternoon session after the company announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity...

Via StockStory

Topics World Trade

3 Value Stocks with Open Questions

September 30, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Via StockStory

Topics Economy Government World Trade

1 of Wall Street’s Favorite Stock to Consider Right Now and 2 Facing Challenges

September 19, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

3 Small-Cap Stocks with Questionable Fundamentals

September 17, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q2

August 26, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including Enovis (NYSE:ENOV) and its peers.

Via StockStory

1 Russell 2000 Stock with Exciting Potential and 2 Facing Headwinds

August 22, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

3 Volatile Stocks We Approach with Caution

August 18, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Artificial Intelligence Economy

Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know

August 12, 2025

A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Stocks

ENOV Q2 Deep Dive: New CEO Prioritizes Organic Growth, Margin Expansion, and Product Pipeline

August 12, 2025

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.5% year on year to $564.5 million. The company’s full-year...

Via StockStory

Enovis’s (NYSE:ENOV) Q2 Sales Beat Estimates, Stock Jumps 10.3%

August 07, 2025

Medical technology company Enovis Corporation (NYSE:ENOV) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.5% year on year to $564.5 million. The company’s...

Via StockStory

Topics Earnings

Enovis Corp (NYSE:ENOV) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss ↗

August 07, 2025

Enovis Corp (ENOV) reported mixed Q2 2025 results, with revenue slightly missing estimates but adjusted EPS beating forecasts. Shares rose 6.9% pre-market as the company raised full-year guidance.

Via Chartmill

Enovis (ENOV) Q2 Revenue Rises 7% ↗

August 07, 2025

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.